HCA Healthcare, Inc. $HCA Stake Raised by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 61,124 shares of the company’s stock after acquiring an additional 1,574 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in HCA Healthcare were worth $23,417,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at about $27,000. Clearstead Trust LLC raised its position in shares of HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares in the last quarter. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare during the second quarter valued at approximately $27,000. Cheviot Value Management LLC acquired a new stake in HCA Healthcare in the first quarter worth approximately $26,000. Finally, Saudi Central Bank acquired a new position in shares of HCA Healthcare during the 1st quarter valued at $26,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts recently weighed in on HCA shares. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $417.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Royal Bank Of Canada increased their target price on shares of HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. Mizuho lifted their price target on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Finally, Barclays raised their price objective on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $474.53.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $478.64 on Wednesday. The company has a 50 day moving average price of $436.04 and a 200 day moving average price of $398.67. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $480.00. The firm has a market capitalization of $109.22 billion, a price-to-earnings ratio of 18.50, a P/E/G ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.